Evidence map›Paper›PMID 40953102›Full record

ArticlePLoS neglected tropical diseases2025

Disability and quality of life assessment using WHODAS-12 items 2.0 and EQ-5D-5L in a rural area endemic for loiasis in the Republic of Congo: A population-based cross-sectional study (the MorLo project).

Marlhand C Hemilembolo, Jérémy T Campillo, Valentin Dupasquier, Elodie Lebredonchel, Samuel Beneteau, Ludovic G Rancé, Glorifié Madoulou Moulabou, Ange Clauvel Niama, Richard R Bileckot, Sébastien D S Pion and 3 more

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Marlhand C HemilemboloUniversité de Montpellier, TransVIHMI, INSERM, Institut de Recherche pour le Développement (IRD), Montpellier, France.
Jérémy T CampilloUniversité de Montpellier, TransVIHMI, INSERM, Institut de Recherche pour le Développement (IRD), Montpellier, France.
Valentin DupasquierDepartment of Cardiology, Montpellier University Hospital, Montpellier, France.
Elodie LebredonchelDepartment of Biochemistry, Hôpitaux Universitaires Paris Nord Val de Seine - site Bichat, Assistance Publique des Hôpitaux de Paris, Paris, France.
Samuel BeneteauUniversité de Montpellier, TransVIHMI, INSERM, Institut de Recherche pour le Développement (IRD), Montpellier, France.
Ludovic G RancéDepartment of Anesthesiology and Critical Care Medicine, Montpellier University Hospital, Montpellier, France.
Glorifié Madoulou MoulabouProgramme National de Lutte contre l'Onchocercose (PNLO), Direction de l'Épidémiologie et de la Lutte contre la Maladie, Ministère de la Santé et de la Population, Brazzaville, Republic of Congo.
Ange Clauvel NiamaFaculté des Sciences de la Santé, Université Marien Ngouabi, Brazzaville, Republic of Congo.
Richard R BileckotFaculté des Sciences de la Santé, Université Marien Ngouabi, Brazzaville, Republic of Congo.
Sébastien D S PionUniversité de Montpellier, TransVIHMI, INSERM, Institut de Recherche pour le Développement (IRD), Montpellier, France.
Michel BoussinesqUniversité de Montpellier, TransVIHMI, INSERM, Institut de Recherche pour le Développement (IRD), Montpellier, France.
François MissamouProgramme National de Lutte contre l'Onchocercose (PNLO), Direction de l'Épidémiologie et de la Lutte contre la Maladie, Ministère de la Santé et de la Population, Brazzaville, Republic of Congo.
Cédric B ChesnaisUniversité de Montpellier, TransVIHMI, INSERM, Institut de Recherche pour le Développement (IRD), Montpellier, France.ORCID 0000-0002-8779-977X

Funding

HORIZON EUROPE European Research Council (ERC) 2020
6 · The paper itself

Abstract

backgroundLoa loa filariasis, a parasitic infection endemic to Central Africa, is a common cause of medical consultation in this region.

methodsTo evaluate the quality of life (QoL) of individuals living in loiasis-endemic areas, we enrolled 991 subjects (one-third being microfilaremic) from the general population of a rural area in the Republic of Congo. QoL and disability were assessed using WHODAS 2.0 12-items and EQ-5D-5L questionnaires. We collected data on the number of eye worm (Ew) and Calabar swelling episodes experienced throughout their lives, as well as individual L. loa microfilarial densities and information on infections with soil-transmitted helminthiasis. PRINCIPAL

findingsIndividuals with a history of Ew had a nearly doubled risk of experiencing at least moderate disability (score >25/100) (adjusted Odds-Ratio = 1.77 (95%CI [1.05-2.99], p = 0.033), compared to those without such a history. Those with more than 10 episodes of Ew during their lifetime had a 28% increase in overall disability as measured by WHODAS. No other variable related to loiasis (Calabar swelling frequency, L. loa microfilarial density and positivity to L. loa antibody rapid test) was associated with the various scores. Additionally, infection with Trichuris trichiura was associated with worse anxiety score (adjusted incidence risk ratio = 1.22 (95% CI [1.06-1.39], p = 0.004)).

conclusionsThe impact of loiasis on daily QoL appears to be primarily due to adult worms rather than microfilarial density. Indeed, our findings strongly suggest that the number of Ew episodes, likely reflecting the cumulative burden of adult worms, is the main correlate of worse QoL scores. These episodes seem to affect multiple dimensions of functioning, with notable impact on mobility, pain, anxiety, and daily activities. In contrast, microfilariae would primarily induce organ dysfunction. Further studies are needed to better understand the respective clinical impacts of adult worms and L. loa microfilariae.

Indexed as

LoiasisPersons with DisabilitiesQuality of LifeAdolescentAdultAgedAnimalsChildCongoCross-Sectional StudiesDisability EvaluationEndemic DiseasesFemaleHumansMaleMiddle Aged

Identifiers

PMID40953102
PMCPMC12449028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.